Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnpario Regulatory News (ANP)

Share Price Information for Anpario (ANP)

Share Price is delayed by 15 minutes
Get Live Data
520.00    5.00 (0.97%)
Bid:
510.00
Ask:
530.00
Spread: 20.00 (3.922%)
Market Cap: £85.47m
ANP Live PriceLast checked at - London Stock Exchange

Intraday Anpario Share Chart

AGM Statement

16 Jun 2022 07:00

RNS Number : 0160P
Anpario PLC
16 June 2022
 

Anpario plc

("Anpario" or the "Company")

 

AGM Statement

 

Anpario plc, the independent manufacturer of natural sustainable animal feed additives for health, nutrition and biosecurity, is holding its AGM later today. Kate Allum, Chairman, will make the following statement:

 

"Group sales for the five months to 31 May 2022 are just ahead of last year which we consider a good performance given China's recent Covid lockdown and the Russia - Ukraine conflict, both of which have affected our sales performance. As anticipated, we experienced significant raw material price inflation, which has remained at elevated levels, and combined with historically high logistics costs has led to a fall in our gross margins. We have though, as a priority, been successfully passing on this inflation through planned sales price increases and overheads are being closely managed.

 

To mitigate the continued disruption in global supply chains we have increased finished goods inventory in our subsidiaries worldwide and increased raw material stockholding at our production site following the recent expansion and upgrade in storage capacity. It is vital that we maintain continuity of supply to our customers who are experiencing significant cost pressures from the high price of animal feed. Encouragingly, international travel and tourism is increasing and should lead to a corresponding uplift in meat consumption. 

 

We are excited by the potential of both existing and new products including pHorce® which is proving its value to pig producers worried about virus-contaminated feed and as a replacement for zinc oxide (ZnO) which is banned in piglet diets from June 2022 in the European Union. Our new omega 3 supplement, Optomega® Algae, has generated a lot of interest due to its sustainable source, from which we expect to convert this interest into growing sales. The Company continues to invest in both product technology and its global sales channels to deliver effective innovative solutions for the animal production industry.

 

We expect the challenging environment to continue until the end of the year, but Anpario's broad range of products, geographic diversity and strong financial position makes for a robust business and gives us confidence in our ability to navigate the current uncertainties and continue with the profitable development of the Company."

 

The Company's interims for the six months period ended 30 June 2021 are expected to be announced on 14 September 2021.

 

 

 

Enquiries:

 

Anpario plc

Richard Edwards, CEO

+44(0) 777 6417 129

Marc Wilson, Group Finance Director

+44(0) 1909 537380

 

Peel Hunt LLP (Nomad and broker)

+44 (0)20 7418 8900

Adrian Trimmings

Andrew Clark

Lalit Bose

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMFFFIFRIIELIF
Date   Source Headline
13th Oct 200611:30 amRNSPossible Acquisition
13th Oct 200611:30 amRNSSuspension - Kiotech Int
29th Sep 20064:56 pmRNSInterim Results - Correction
27th Sep 20067:00 amRNSInterim Results
5th Sep 20062:46 pmRNSDirectorate Change
23rd Aug 20069:10 amRNSDiv currency conversion rate
22nd Aug 200610:28 amRNSDoc re. Interim Report
21st Aug 20069:11 amRNSDirector/PDMR Shareholding
18th Aug 20061:57 pmRNSDirector/PDMR Shareholding
10th Aug 200611:27 amRNSDirector/PDMR Shareholding
7th Aug 200610:20 amRNSDirector/PDMR Shareholding
31st Jul 20068:00 amRNSInterim Results
28th Jul 200611:00 amRNSDirectorate Change
12th Jul 200611:00 amRNSTrading Statement
3rd Jul 20067:00 amRNSChange of Adviser
19th Jun 20064:57 pmRNSNotice of AGM
7th Jun 20063:05 pmRNSDirector/PDMR Shareholding
6th Jun 20067:01 amRNSFinal Results
5th Jun 20064:23 pmRNSChange in registered office
16th May 20063:48 pmRNSDirectorate Change
16th May 20063:44 pmRNSDirectorate Change
10th May 20063:02 pmRNSDirector/PDMR Shareholding
10th May 20062:52 pmRNSChanges to Board
9th May 20061:11 pmRNSDirector/PDMR Shareholding
8th May 20062:55 pmRNSDividend Declaration
8th May 20062:50 pmRNSDirector/PDMR Shareholding
5th May 20064:09 pmRNSDirector/PDMR Shareholding
28th Apr 20062:23 pmRNSDirector/PDMR Shareholding
28th Apr 20062:01 pmRNSDirector/PDMR Shareholding
26th Apr 20064:00 pmRNSAnooraq-Anglo Plats Project
19th Apr 20062:00 pmRNSDirector/PDMR Shareholding
12th Apr 20063:09 pmRNSRhodium Contract Sales
12th Apr 20062:00 pmRNSStatement re. Anglo Platinum
29th Mar 200612:04 pmRNSResults of AGM
20th Mar 20062:00 pmRNSDirector/PDMR Shareholding
15th Mar 200610:00 amRNSCurrency conversion rate
23rd Feb 20069:00 amRNSDirectorate Change
13th Feb 20067:15 amRNSResults of Subsidiary
13th Feb 20067:01 amRNSKola licences agreed
13th Feb 20067:00 amRNSFinal Results
19th Jan 200612:04 pmRNSTrading Statement
10th Jan 200612:21 pmRNSBlocklisting Interim Review
10th Jan 200612:11 pmRNSBlocklisting Interim Review
6th Jan 200612:01 pmRNSAdditional Listing
20th Dec 20059:26 amRNSDirector/PDMR Shareholding
15th Dec 200510:00 amRNSPool agreement at Marikana
30th Nov 20054:30 pmRNSIssue of Options
24th Oct 20054:25 pmRNSDirector/PDMR Shareholding
30th Sep 20057:03 amRNSInterim Results
30th Sep 20057:01 amRNSRapala Deal and Board Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.